Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Special Correspondent

IIT Madras designed study on COVID-19 drug published in Nature magazine

A study on a drug used to treat COVID-19 patients by a nephrologist and a professor of the Indian Institute of Technology Madras has been published in a peer-reviewed journal Nature. The article, ”An open label randomised clinical trial of indomethacin for mild and moderate hospitalised Covid-19 patients” was published on April 19.

The study used a nonsteroidal anti-inflammatory drug indomethacin to treat over 200 persons with mild and moderate COVID-19 symptoms during the first and second wave.

Rajan Ravichandran, an adjunct faculty in the institute and director of nephrology at MIOT Hospital, and R. Krishna Kumar, institute professor, conducted the study.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.